A bdominal pain is a cardinal feature of acute pancreatitis (AP), and thoracic epidural analgesia (TEA) has been studied as an advanced analgesic strategy in AP. 1 Aside from analgesia, TEA has secondary effects of sympathetic blockade, which may lead to splanchnic vasodilation and improvement of pancreatic microcirculation. 2 Thoracic epidural analgesia has hence been evaluated as a disease-modifying therapy for AP in clinical studies. 3,4 We performed a systematic review to assess the safety of TEA and its impact on clinical outcomes in AP.
MATERIALS AND METHODSThis systematic review was performed in accordance to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines and was registered in PROSPERO (CRD42021281548). A literature search was performed on MEDLINE, Embase, and the Cochrane Li-brary from inception until September 15, 2021, with the MeSH terms and synonyms of (1) "epidural analgesia" and (2) "acute pancreatitis." Original studies on TEA in AP patients were included, with no limit on publication date. The articles were independently screened by 2 reviewers for inclusion and data extraction.Risk of bias and level of evidence were assessed with the Cochrane Risk of Bias tool and the Grades of Recommendation, Assessment, Development, and Evaluation system, respectively.